Author: Andi Thornton
Update on Spinraza appraisal process
Update on the regulatory appraisal process of Spinraza in England and Wales
TreatSMA is looking for a trustee
TreatSMA is looking for a trustee!
New Standard of Care in SMA is published
A new document on Standard of Care in spinal muscular atrophy has been published.
Google blocks TreatSMA email system again
Google deprives TreatSMA of access to email and data again
Thank you, George’s Family!
TreatSMA would like to thank the Family of little fighter George for raising £2,750 in support of TreatSMA.
Incredible effects of new compound RG7916 on SMN protein levels
Exciting news about RG7916 efficacy in SMA
Switzerland will fund Spinraza treatment
The Swiss Office for Social Security announced today that Spinraza will be funded across all types of spinal muscular atrophy in Switzerland.
Portugal will fund Spinraza treatment
Portuguese national health service has decided to offer Spinraza treatment.